San Antonio, the gateway to South Texas, is the 7*^ largest city in the US and the largest metropolitan area with a majority Hispanic population (63%). South Texas is about the size of Ohio, and comprises an impoverished and largely Hispanic population with disproportionate rates of diabetes and obesity, exacerbated by a lack of health insurance and poor access to health care. This region also contains numerous US military installations, and active-duty service members and veterans often have special health issues, including Increased risk for post-traumatic stress disorder and traumatic injuries. Unfortunately, neither better access to care nor improved care delivery can eliminate health disparities and meet these complex needs, in addition, research across the full T l to T4 translational spectrum is required to eliminate knowledge gaps and establish real-world effectiveness that improves health care for our populations. In 2006, UTHSCSA established the Institute for Integration of Medicine and Science (IIMS) to improve health and reduce disparities by accelerating scientific discoveries and applications across the full translational research spectrum. For example, IIMS expanded the number of clinical research units that extend to the Texas-Mexico border from 1 to 7, and dramatically increasing participant access to clinical and translational science. We increased, from 2 to 6, the Practice-Based Research Networks that focus on diverse ambulatory populations. Efforts to address translational science workforce needs over the past 5-10 years have graduated 100 Masters Clinical Investigation students, supported 19 successful KL2 Scholars, and established new joint Translational Science PhD and Certificate programs. In this proposal, we provide strategies to spur clinical and translational science evolution, catalyze research teams, and implement programs that produce creative, collaborative, and culturally diverse scientists.
Our Specific Aims will: 1. Accelerate clinical and translational research innovation and effective team science along the entire 11 to T4 research spectrum by providing an academic home integrated with our strategic partner institutions. 2. Expand, diversify, and enhance the workforce of interdisciplinary translational biomedical scientists. 3. Implement effective methods to continuously evaluate and optimize services, increase efficiencies, improve processes, and reduce costs across all IIMS programs.

Public Health Relevance

Based on our vision of improving the health status of South Texas by accelerating scientific discoveries and public health applications, we will deploy strategic resources that focus on prevalent challenges in our region, including: 1) the health needs of our underserved Hispanic population, 2) the special health issues facing active-duty military and veteran populations, and 3) limitations in the translational science workforce required to fill in critical knowledge gaps and improve health in South Texas and the US.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR001120-02S1
Application #
8916918
Study Section
Special Emphasis Panel (ZAI1-PTM-C (S1))
Program Officer
Merchant, Carol
Project Start
2013-09-26
Project End
2018-04-30
Budget Start
2014-09-06
Budget End
2015-03-05
Support Year
2
Fiscal Year
2014
Total Cost
$109,498
Indirect Cost
$36,255
Name
University of Texas Health Science Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Overbaugh, Kristen J; Zaragoza, Gabriela; White, Carole (2018) The Formation of a Community Academic Partnership to Address Health Disparities and Improve Outcomes for Latino Family Caregivers Living in a Rural Community. Issues Ment Health Nurs :1-3
Chen, Cang; Li, Xiuhua; Ge, Guo et al. (2018) GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice. Sci Rep 8:5460
Le Clec'h, Winka; Chevalier, Frédéric D; McDew-White, Marina et al. (2018) Whole genome amplification and exome sequencing of archived schistosome miracidia. Parasitology 145:1739-1747
Wall, Gina; Chaturvedi, Ashok K; Wormley Jr, Floyd L et al. (2018) Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development. Antimicrob Agents Chemother 62:
Lopez-Cruzan, Marisa; Roache, John D; Hill-Kapturczak, Nathalie et al. (2018) Pharmacokinetics of Phosphatidylethanol 16:0/20:4 in Human Blood After Alcohol Intake. Alcohol Clin Exp Res 42:2094-2099
Park, Min Ju; Shen, Hailian; Spaeth, Jason M et al. (2018) Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19. J Biol Chem 293:4870-4882
Mathias, Charles W; Hill-Kapturczak, Nathalie; Karns-Wright, Tara E et al. (2018) Translating transdermal alcohol monitoring procedures for contingency management among adults recently arrested for DWI. Addict Behav 83:56-63
Schmidt, Susanne; Shay, L Aubree; King, Harriet V et al. (2018) A New Lease on Life: Preliminary Needs Assessment for the Development of a Survivorship Program for Young Adult Survivors of Cancer in South Texas. J Pediatr Hematol Oncol 40:e154-e158
Schmidt, Susanne; Shay, Laura Aubree; Saygin, Can et al. (2018) Improving pilot project application and review processes: A novel application of lean six sigma in translational science. J Clin Transl Sci 2:135-138
Kraig, Ellen; Linehan, Leslie A; Liang, Hanyu et al. (2018) A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects. Exp Gerontol 105:53-69

Showing the most recent 10 out of 548 publications